SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000769993-14-000245
Filing Date
2014-02-13
Accepted
2014-02-13 13:59:43
Documents
1
Group Members
GS INVESTMENT STRATEGIES, LLC

Document Format Files

Seq Description Document Type Size
1 infinitypharmaceuticals0gsam.txt SC 13G 17173
  Complete submission text file 0000769993-14-000245.txt   18995
Mailing Address 780 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 780 MEMORIAL DRIVE CAMBRIDGE MA 02139 6174531000
INFINITY PHARMACEUTICALS, INC. (Subject) CIK: 0001113148 (see all company filings)

IRS No.: 330655706 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-60943 | Film No.: 14604938
SIC: 2834 Pharmaceutical Preparations

Mailing Address 200 WEST STREET NEW YORK NY 10282
Business Address 200 WEST STREET C/O GOLDMAN SACHS & CO. NEW YORK NY 10282 312-655-4400
GOLDMAN SACHS ASSET MANAGEMENT, L.P. (Filed by) CIK: 0001229262 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: SC 13G